Article citationsMore>>

Estrada-Luna, D., Ortiz-Rodriguez, M.A., Medina-Briseno, L., Carreon-Torres, E., Izquierdo-Vega, J.A., Sharma, A., Cancino-Diaz, J.C., Pérez-Méndez, O., Belefant-Miller, H. and Betanzos-Cabrera, G. (2018) Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease. Molecules, 23, E2730.
https://doi.org/10.3390/molecules23112730

has been cited by the following article:

• TITLE: Dietary Effect of Squalene on Lipid Metabolism of Obese/Diabetes KK-Ay Mice and Wild-Type C57BL/6J Mice

  AUTHORS: Shaokai Liu, Masashi Hosokawa, Kazuo Miyashita

  KEYWORDS: Squalene; KK-Ay Mice; C57BL/6J Mice; HDL Cholesterol, Atherosclerosis

  JOURNAL NAME: Food and Nutrition Sciences, Vol.9 No.12, December 29, 2018

  ABSTRACT: The purpose of this study was to evaluate the influence of squalene (SQ) on plasma and hepatic lipid levels of obese/diabetic KK-Ay mice and wild-type C57BL/6J mice. SQ supplementation significantly increased the HDL cholesterol of KK-Ay mice, which was paralleled with no significant difference in the total and non-HDL cholesterol levels. The increase in HDL cholesterol was also found in the plasma of normal C57BL/6J mice, but the difference was not significant. SQ administration significantly increased neutral lipids (NL) in the liver of KK-Ay mice, while no significant difference was observed in the polar lipids and the total cholesterol levels. The increase in NL was primarily due to the increase in TAG. However, the cholesterol level significantly increased due to SQ intake in the liver of C57BL/6J mice, while no significant difference was found in other lipid levels. The present study suggests that SQ may effectively increase HDL cholesterol level, an important anti-atherosclerotic factor, especially in subjects with metabolic disorders.